GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Total Assets

Krebs Biochemicals & Industries (BOM:524518) Total Assets : ₹1,781.7 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Total Assets?

Krebs Biochemicals & Industries's Total Assets for the quarter that ended in Mar. 2024 was ₹1,781.7 Mil.

Warning Sign:

If a company builds assets at 7.9% a year, faster than its revenue growth rate of 6% over the past 5 years, it means that the company may be getting less efficient.

During the past 3 years, the average Total Assets Growth Rate was 3.30% per year. During the past 5 years, the average Total Assets Growth Rate was 7.90% per year. During the past 10 years, the average Total Assets Growth Rate was 4.50% per year.

During the past 13 years, Krebs Biochemicals & Industries's highest 3-Year average Total Assets Growth Rate was 14.90%. The lowest was -15.30%. And the median was 3.30%.

Total Assets is connected with ROA %. Krebs Biochemicals & Industries's annualized ROA % for the quarter that ended in Mar. 2024 was -13.13%. Total Assets is also linked to Revenue through Asset Turnover. Krebs Biochemicals & Industries's Asset Turnover for the quarter that ended in Mar. 2024 was 0.07.


Krebs Biochemicals & Industries Total Assets Historical Data

The historical data trend for Krebs Biochemicals & Industries's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Total Assets Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,338.00 1,592.20 1,898.06 1,749.82 1,781.75

Krebs Biochemicals & Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,749.82 - 1,781.28 - 1,781.75

Krebs Biochemicals & Industries Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Krebs Biochemicals & Industries's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=-1192.167+2973.914
=1,781.7

Krebs Biochemicals & Industries's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=-1192.167+2973.914
=1,781.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krebs Biochemicals & Industries  (BOM:524518) Total Assets Explanation

Total Assets is connected with ROA %.

Krebs Biochemicals & Industries's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-233.876/( (0+1781.747)/ 1 )
=-233.876/1781.747
=-13.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Krebs Biochemicals & Industries's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=119.729/( (0+1781.747)/ 1 )
=119.729/1781.747
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Krebs Biochemicals & Industries Total Assets Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries (BOM:524518) Business Description

Traded in Other Exchanges
Address
Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines